Limb-Girdle Muscular Dystrophy Panel

Concurrent analysis of multiple genes associated with muscular dystrophies characterized by progressive muscle disease with prominent proximal weakness and wasting.

NY Approved

Test Overview

Clinical Utility

  • Molecular confirmation of a clinical diagnosis
  • Identification of at-risk family members
  • Assist with management/treatment decisions
  • Recurrence risk

Test Details

Genes

ANO5, BVES, CAPN3, CAV3, DES, DMD, DNAJB6, DOK7, DYSF, FKRP, FKTN, GAA, GMPPB, LMNA, MYOT, PNPLA2, POGLUT1, POMGNT1, POMK, POMT1, POMT2, SGCA, SGCB, SGCD, SGCG, SQSTM1, TCAP, TNPO3, TOR1AIP1, TRAPPC11, TRIM32, TTN, VCP

Conditions

  • Limb-Girdle Muscular Dystrophy (LGMD)
  • Muscular Dystrophy-Dystroglycanopathy (LGMD)
  • Walker–Warburg Syndrome

Lab Method

  • Deletion/Duplication Analysis
  • Next-Gen Sequencing

Ordering Information

Test Code: 890
CPT Codes*: 81404x2, 81405x2, 81406x2, 81408x2, 81479x3, 81161x1
ABN Required: No
Turnaround Time**: 4 weeks
Preferred Specimen: 2-5 mL Blood - Lavender Top Tube
Alternative Specimen: Buccal Swabs

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.

Resources

Test Documents

Billing

Targeted Variant Testing

FAQs